JPRN-UMIN000033122招募中未知
Denosumab and Alendronate, Examination of the effective of Glucocorticoid-induced Osteoporosis - Denosumab and Alendronate, Examination of the effective of Glucocorticoid-induced Osteoporosis
The First Department of Internal Medicine University of Occupational and Environmental Health, Japan, School of Medicine0 个研究点目标入组 200 人开始时间: 2018年6月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients falling under any of the following are excluded from this research. 1)Patients who may be pregnant or pregnant, patients who desire pregnancy 2)Patients already taking steroids 3)Patients receiving donosumab or bisphosphonate 4)Patient with a disorder delaying esophageal passage such as esophageal stenosis or achalasia (esophageal relaxation disorder) 5)Patients who are raising their upper body for more than 30 minutes or who can not stand 6)Patients with a history of hypersensitivity to denosumab and alendronate or other bisphosphonates. 7)Patients with hypocalcemia 8)Patients judged inappropriate as subjects by the attending physician
研究者
相似试验
招募中
不适用
The effects of denosumab compared with alendronate on glucocorticoid-induced osteoporosis in patients with malignant lymphomaglucocorticoid-induced osteoporosis in patients with malignant lymphomaJPRN-UMIN000038881Toyama University Hospital Department of Hematology100
已完成
不适用
Effect of Denosumab and Alendronate on glucocorticoid-induced osteoporosis in patients with glomerulonephritis:a randomized controlled trialJPRN-UMIN000019574Showa University School of Medicine30
招募中
不适用
Effects of alendronate and denosumab on glucocorticoid-induced osteoporosis by a randomized, open-labeled studyJPRN-UMIN000019642Gifu University Graduate School of Medicine60
已完成
4 期
RA Denosumab on Bone Microstructure StudyRheumatoid ArthritisNCT01770106Chinese University of Hong Kong40
招募中
不适用
Comparison of therapeutic effects of denosumab and romosozumab using Propensity Score Matching in postmenopausal osteoporosis patientsPrimary osteoprosisosteoprosisD0 1 0 0 2 4JPRN-jRCT1041200090Kobayakawa Tomonori150